Tamoxifen, raloxifene, and the prevention of breast cancer.
about
CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinantThe chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancerSteroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancerBringing estrogen receptors under control.Proteasome inhibitors: their effects on arachidonic acid release from cells in culture and arachidonic acid metabolism in rat liver cellsTamoxifen stimulates arachidonic acid release from rat liver cells by an estrogen receptor-independent, non-genomic mechanismTamoxifen and the Rafoxifene analog LY117018: their effects on arachidonic acid release from cells in culture and on prostaglandin I2 production by rat liver cellsChemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast CancerFoxl2, a forkhead transcription factor, modulates nonclassical activity of the estrogen receptor-alphaChemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancerTransactivation Function-2 of Estrogen Receptor α Contains Transactivation Function-1-regulating ElementBreast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexesChemopreventive Activity of Honokiol against 7, 12 - Dimethylbenz[a]anthracene-Induced Mammary Cancer in Female Sprague Dawley Rats.Tamoxifen prevention of breast cancer: an instance of the fingerpost.Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.Raloxifene and/or estradiol decrease anxiety-like and depressive-like behavior, whereas only estradiol increases carcinogen-induced tumorigenesis and uterine proliferation among ovariectomized rats.The role of encapsulation by β-cyclodextrin in the interaction of raloxifene with macromolecular targets: a study by spectroscopy and molecular modeling.Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis.The multifaceted mechanisms of estradiol and estrogen receptor signaling.Tracking progesterone receptor-mediated actions in breast cancerChallenges in the gynecologic care of premenopausal women with breast cancer.Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates.Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway.Breast cancer, stem cells and prospects for therapy.The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future OpportunitiesThe naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.New insights on the role of hormonal therapy in ovarian cancerInhibition of EGFR autophosphorylation plays an important role in the anti-breast cancer efficacy of the dithiocarbamate derivative TM208.Derailed estrogen signaling and breast cancer: an authentic couple.Bioactivation of Selective Estrogen Receptor Modulators (SERMs)Indirect androgen doping by oestrogen blockade in sports.Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPERDo Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?Lactoferrin and cancer disease prevention.Evolution of the tissue selective estrogen complex (TSEC).Low-dose tamoxifen treatment in juvenile males has long-term adverse effects on the reproductive system: implications for inducible transgenics.Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line.Estrogen receptor-KRAB chimeras are potent ligand-dependent repressors of estrogen-regulated gene expression.Raloxifene as a multifunctional medicine? Current trials will show whether it is effective in both osteoporosis and breast cancer.
P2860
Q24290613-6A2C34D7-9E17-42AD-9605-5820A82FB138Q24628910-546D7479-2BC2-4DC8-991E-38464BF6E251Q24680310-544A1EF6-125D-4284-98E4-C9430D4EA3F9Q24800471-767D3AC9-BA3F-4A5A-B507-2A7B7B1BB797Q24801210-20D045E5-0377-40C8-AC32-56CE032E8976Q24803019-0B0D5794-B625-48B8-8C50-077BF66ED8DFQ24803303-95A19E61-9BC4-424D-92CB-048806C9A617Q28343780-9B0A5C6A-A1D0-4FE6-958E-7085E84600E0Q28511818-76F32750-5F27-4A9A-96E9-E01C59424096Q28680653-A988134D-DA17-46ED-9733-3F1611CEDB41Q30375133-168B6967-354D-4809-B09B-A40CD9A19E37Q30409045-A59FB4F0-42F5-4902-A347-A89FC4B73CCDQ33742294-558A61E4-7FB3-4A94-AA09-26196EB5AF55Q33765698-747986BE-C2FF-4505-860A-53204F48E8F1Q33852622-22393900-F441-4C1F-9BB5-094A0EE5664DQ33911975-702FE655-E55C-40EE-877D-E487254B2A55Q33990468-F9D6FF1A-1A9E-4FE7-9E4F-9112553D44B8Q33994291-28B8B984-5885-4722-98FE-95EFC7932749Q34311547-9F821D18-8D06-4EA2-951F-F72007E9477BQ34388848-EAAF45B2-01E4-48A9-8383-007E25919AAEQ34616059-BF0BBDB3-A3DF-45CA-A7A9-A7F91BC1AD2DQ34646634-ADCEA989-8F37-460D-8E03-9A0FF1AFA44AQ34812814-6C494CBD-5E2D-48A4-B13A-676D5B31EB08Q34993839-29C148E0-C6DC-4866-82C1-142514EE9998Q35012847-2166190D-DEE8-4589-90B3-92873160C53DQ35185640-D50B27D2-2C67-42A5-B1A6-7757E289DB76Q35869879-E1BA750F-40C5-4A84-8EB9-0E0E36C3C5FAQ36001247-A199832B-7E0B-4F68-BD34-D9B77991FB71Q36295330-9AB40E45-0961-4A43-9A8B-98CAF45E0D92Q36589361-617C8C87-7C9B-48DD-A9B1-5A07E0000BCCQ36595120-08AAD613-5C9B-44FC-A35F-8A23672D13C0Q36736110-381401B2-DDE2-4542-9714-6BB52C5C8A31Q36800401-2DFD384C-8F8A-4ABD-86BD-6126F433A00BQ37143825-1FCDC28F-CB74-4B54-8EC9-5197B88AE328Q37353959-51064C58-3C36-4451-ACE5-825E15965D25Q38077503-5C17E32C-0799-4F16-A677-5D3BBC577DBDQ38368087-7AE55735-E40C-4196-9551-208189AB09B3Q39778278-A53AA4E9-6621-4DFB-858A-DD0A2E5710FDQ42487378-0999AA02-F1C1-412A-A349-B8512D5CF14FQ42785667-BC37AE53-C9E7-4913-BD3B-83374D746E34
P2860
Tamoxifen, raloxifene, and the prevention of breast cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Tamoxifen, raloxifene, and the prevention of breast cancer.
@ast
Tamoxifen, raloxifene, and the prevention of breast cancer.
@en
type
label
Tamoxifen, raloxifene, and the prevention of breast cancer.
@ast
Tamoxifen, raloxifene, and the prevention of breast cancer.
@en
prefLabel
Tamoxifen, raloxifene, and the prevention of breast cancer.
@ast
Tamoxifen, raloxifene, and the prevention of breast cancer.
@en
P356
P1433
P1476
Tamoxifen, raloxifene, and the prevention of breast cancer.
@en
P2093
P304
P356
10.1210/ER.20.3.253
P577
1999-06-01T00:00:00Z